Xiaoduo Fan, MD, MPH

UMass Mind Clinical and Research Program, UMass Memorial Health/University of Massachusetts Chan Medical School, Worcester, Massachusetts

  • 4Articles
  • 11.7KReads
  • 2007–2025Active
  • 18Collaborators
  • 110Citations

About

Xiaoduo Fan, MD, MPH, is affiliated with the UMass Mind Clinical and Research Program at UMass Memorial Health and the University of Massachusetts Chan Medical School in Worcester, Massachusetts. The author has published extensively on schizophrenia and schizoaffective disorders, with a focus on pharmacological treatments and co-occurring metabolic disorders. Topics studied include the use of brexpiprazole and modafinil in schizophrenia, as well as metabolic indicators such as triglyceride/HDL cholesterol ratio and hemoglobin A1c in patients receiving atypical antipsychotics. Fan's work spans from 2007 to 2025 and includes collaborations with several frequent co-authors.

Publications

JCP
Brexpiprazole for the Treatment of Co-Occurring Schizophrenia and Substance Use Disorder
Original Research

Brexpiprazole for the Treatment of Co-Occurring Schizophrenia and Substance Use Disorder

October 13, 2025

This pilot trial suggests that brexpiprazole might be beneficial in reducing substance craving and use and improve quality of life in this difficult-to-treat patient population.
, , , et al
JCP
Original Research

The Triglyceride/HDL Cholesterol Ratio

November 2, 2010

Read the full study on using the Triglyceride/HDL Cholesterol Ratio to predict Insulin Resistance and Low-Density Lipoprotein Cholesterol Particle Size.
, , , et al
JCP
Original Research

Modafinil for Clozapine-Treated Schizophrenia Patients: A Double-Blind, Placebo-Controlled Pilot Trial

August 11, 2009

, , , et al
JCP
Original Research

Elevated Hemoglobin A1c as a Possible Indicator of Diabetes Mellitus and Diabetic Ketoacidosis in Schizophrenia Patients Receiving Atypical Antipsychotics

April 16, 2007

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe